How do patients rate their subjective symptoms after CNGA3 gene therapy: First application of the instrument A3-PRO

Category Primary study
JournalInvestigative Ophthalmology and Visual Science
Year 2017
This article has no abstract
Epistemonikos ID: 2a97bce3a6610b5da1841b170b99f7dfb143686f
First added on: Feb 09, 2025